Minimally Invasive Urinary Incontinence Device Market Outlook For 2026–2030 Covering Growth Drivers And Industry Trends
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Changes In Market Value Are Expected For The Minimally Invasive Urinary Incontinence Device Market Over The 2026–2030 Period?
The market size for minimally invasive urinary incontinence devices has experienced substantial growth in recent years. It is forecast to expand from $1.25 billion in 2025 to $1.37 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.1%. Historically, this expansion has been driven by several factors, including a reliance on traditional open surgical procedures, limited device options for urinary incontinence, growing awareness of female pelvic health, increasing hospital and clinic-based procedures, and the adoption of tension-free vaginal tape (tvt) systems.
The minimally invasive urinary incontinence device market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $1.91 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.8%. This anticipated growth during the forecast period is attributable to several factors, including the creation of sophisticated mid-urethral and single-incision sling systems, increased capital flow into home healthcare equipment, a growing elderly demographic alongside higher rates of incontinence, the approval of novel bulking agents and artificial urinary sphincters by regulatory bodies, and the incorporation of smart and robotic-assisted surgical technologies. Key trends anticipated during this period encompass the wider acceptance of minimally invasive surgical techniques, an increase in urinary incontinence occurrences linked to an aging populace, a growing inclination towards managing healthcare at home, the expansion of mid-urethral sling and sling systems, and an emphasis on minimizing both recovery periods and surgical risks.
Access Your Free Sample Report For In-Depth Market Analysis:
What Major Factors Are Driving The Minimally Invasive Urinary Incontinence Device Market Forward?
The rising occurrence of prostate cancer is anticipated to boost the minimally invasive urinary incontinence device market going forward. Prostate cancer involves the unregulated proliferation of cells within the prostate gland, potentially affecting urinary and reproductive health. The increasing prevalence of prostate cancer is largely propelled by an aging male population, as advanced age presents a significant risk factor for the condition. Minimally invasive urinary incontinence devices play a role in managing urinary complications associated with prostate cancer by offering targeted assistance to control bladder leakage, reinstate normal urinary function, and considerably enhance patients’ overall quality of life during treatment or recovery. For example, in June 2025, as per the Centers for Disease Control and Prevention, a US-based government agency, in the United States, an estimated 255,395 new cases of prostate cancer were identified in 2022, and by 2023, the illness accounted for the deaths of approximately 33,881 men. Thus, the growing incidence of prostate cancer is stimulating the expansion of the minimally invasive urinary incontinence device market.
What Are The Main Segments Within The Minimally Invasive Urinary Incontinence Device Market Segment Structure?
The minimally invasive urinary incontinence device market covered in this report is segmented –
1) By Type: Tension Free Vaginal Tape (TVT), Tension Free Vaginal Tape (TVT) Obturator System, Other Types
2) By Age Group: Adults (18-65 years), Senior Population (65 Years And Above), Pediatric Population
3) By End-User: Hospitals, Clinics, Home Healthcare Settings, Research Institutions
Subsegments:
1) By Tension Free Vaginal Tape (TVT): Mid Urethral Sling, Retropubic Sling, Single Incision Sling
2) By Tension Free Vaginal Tape Obturator System (TVTO): Inside Out Approach, Outside In Approach
3) By Other Types: Bulking Agents, Artificial Urinary Sphincter, Sling Systems
Which Trends Are Impacting The Progress Of The Minimally Invasive Urinary Incontinence Device Market?
Leading firms within the minimally invasive urinary incontinence device market are concentrating on creating sophisticated products, including neuromodulation therapy devices, to provide efficient and enduring solutions that require minimal surgical involvement. These neuromodulation therapy devices are implants designed to stimulate nerves responsible for bladder control, thereby regulating urinary function and assisting in incontinence management through improved bladder control and a reduction in unintentional leakage. An example of this is BlueWind Medical Ltd., a US-based manufacturer of neurostimulation devices, which introduced its Revi implantable tibial neuromodulation (iTNM) device in December 2023. This particular device is a battery-free, minimally invasive implant developed to address urge urinary incontinence (UUI) by stimulating the posterior tibial nerve. Implantation of the device occurs near the ankle during a single outpatient visit under local anesthesia, and it is activated via a lightweight wearable, enabling patients to comfortably manage their symptoms from home. This introduction highlights the continuing trend of bringing innovative and patient-centric neuromodulation options to the urinary incontinence device market.
Who Are The Companies Participating In The Minimally Invasive Urinary Incontinence Device Market?
Major companies operating in the minimally invasive urinary incontinence device market are Johnson & Johnson Services Inc., Medtronic plc, Becton Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Coloplast A/S, Teleflex Incorporated, Hollister Incorporated, CooperSurgical Inc., B. Braun Melsungen Aktiengesellschaft, LiNA Medical ApS, BlueWind Medical Ltd., Caldera Medical Inc., Neuspera Medical Inc., InControl Medical LLC, UroMems Inc., Rigicon Inc., Valencia Technologies Corporation, Zephyr Surgical Implants SA
Get The Full Minimally Invasive Urinary Incontinence Device Market Report:
Which Region Represents The Largest Share Of The Minimally Invasive Urinary Incontinence Device Market?
North America was the largest region in the minimally invasive urinary incontinence device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive urinary incontinence device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Minimally Invasive Urinary Incontinence Device Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Minimally Invasive Urinary Incontinence Device Market 2026, By The Business Research Company
Personal Finance Software Market Report 2026
https://www.thebusinessresearchcompany.com/report/personal-finance-software-global-market-report
Personal Finance Apps Market Report 2026
https://www.thebusinessresearchcompany.com/report/personal-finance-apps-global-market-report
Financial Planning Software Market Report 2026
https://www.thebusinessresearchcompany.com/report/financial-planning-software-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
